Related references
Note: Only part of the references are listed.Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease
Ji Hye Hong et al.
JOURNAL OF LIPID RESEARCH (2016)
Spatial neuroproteomics using imaging mass spectrometry
Jorg Hanrieder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Explorative and targeted neuroproteomics in Alzheimer's disease
Ann Brinkmalm et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Neuroproteomics tools in clinical practice
Ganna Shevchenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Proteomic developments in the analysis of formalin-fixed tissue
Ove J. R. Gustafsson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris et al.
BMC MEDICINE (2015)
Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
Megan J. Ehret et al.
CLINICAL THERAPEUTICS (2015)
Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease
Gael Le Douaron et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples
Achim Buck et al.
JOURNAL OF PATHOLOGY (2015)
MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice
Michaela Aichler et al.
LABORATORY INVESTIGATION (2015)
Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: Potential roles in GABAergic interneuron pathology
Klaus Oliver Schubert et al.
SCHIZOPHRENIA RESEARCH (2015)
Commercialisation of Biomarker Tests for Mental Illnesses: Acvances one Obstacles
Man K. Chan et al.
TRENDS IN BIOTECHNOLOGY (2015)
Reduced protein synthesis in schizophrenia patient-derived olfactory cells
J. A. English et al.
TRANSLATIONAL PSYCHIATRY (2015)
MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney
Ove J. R. Gustafsson et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry
Thomas W. Powers et al.
BIOMOLECULES (2015)
Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies
Aaron M. Swomley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Human SOD1-G93A Specific Distribution Evidenced in Murine Brain of a Transgenic Model for Amyotrophic Lateral Sclerosis by MALDI Imaging Mass Spectrometry
Elena Acquadro et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Direct Targeted Quantitative Molecular Imaging of Neurotransmitters in Brain Tissue Sections
Mohammadreza Shariatgorji et al.
NEURON (2014)
Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology
Mohammadreza Shariatgorji et al.
NEUROPSYCHOPHARMACOLOGY (2014)
MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain
Hanane Kadar et al.
NEUROTOXICITY RESEARCH (2014)
MALDI Imaging Mass Spectrometry Profiling of N-Glycans in Formalin-Fixed Paraffin Embedded Clinical Tissue Blocks and Tissue Microarrays
Thomas W. Powers et al.
PLOS ONE (2014)
Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis
Virginie Licker et al.
PROTEOMICS (2014)
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease
Dai Yuki et al.
SCIENTIFIC REPORTS (2014)
Matrix Assisted Laser Desorption Ionization Imaging Mass Spectrometry Workflow for Spatial Profiling Analysis of N-Linked Glycan Expression in Tissues
Thomas W. Powers et al.
ANALYTICAL CHEMISTRY (2013)
Mass spectrometry imaging with high resolution in mass and space
Andreas Roempp et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2013)
MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis
Jorg Hanrieder et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients
Ameer Y. Taha et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A critical overview of animal models of psychiatric disorders: challenges and perspectives
Joao Vinicius Salgado et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2013)
The genetics and neuropathology of Parkinson's disease
Henry Houlden et al.
ACTA NEUROPATHOLOGICA (2012)
Internal calibrants allow high accuracy peptide matching between MALDI imaging MS and LC-MS/MS
Johan O. R. Gustafsson et al.
JOURNAL OF PROTEOMICS (2012)
Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
K. O. Schubert et al.
MOLECULAR PSYCHIATRY (2012)
Proteomic analysis of human hippocampus shows differential protein expression in the different hippocampal subfields
Melanie Foecking et al.
PROTEOMICS (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry
Junya Matsumoto et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
The Neuroproteomics of Schizophrenia
Jane A. English et al.
BIOLOGICAL PSYCHIATRY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
From brain to food: Analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry
Marcus O. W. Grimm et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
L-DOPA-induced Dyskinesia is Associated with Regional Increase of Striatal Dynorphin Peptides as Elucidated by Imaging Mass Spectrometry
Jorg Hanrieder et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
HYDROXYLATED AND NON-HYDROXYLATED SULFATIDE ARE DISTINCTLY DISTRIBUTED IN THE HUMAN CEREBRAL CORTEX
D. Yuki et al.
NEUROSCIENCE (2011)
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease
Anna Ljungdahl et al.
PLOS ONE (2011)
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Claire Henchcliffe et al.
PROGRESS IN NEUROBIOLOGY (2011)
Differential regulation of FGF-2 in neurons and reactive astrocytes of axotomized rat hypoglossal nucleus. A possible therapeutic target for neuroprotection in peripheral nerve pathology
Gabriela Pintar de Oliveira et al.
ACTA HISTOCHEMICA (2010)
Citric Acid Antigen Retrieval (CAAR) for Tryptic Peptide Imaging Directly on Archived Formalin-Fixed Paraffin-Embedded Tissue
Johan O. R. Gustafsson et al.
JOURNAL OF PROTEOME RESEARCH (2010)
INNOVATION Molecular imaging by mass spectrometry - looking beyond classical histology
Kristina Schwamborn et al.
NATURE REVIEWS CANCER (2010)
Proteomics in animal models of Alzheimer's and Parkinson's diseases
Rena A. Sowell et al.
AGEING RESEARCH REVIEWS (2009)
Clioquinol Decreases Amyloid-beta Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease
Cristina Grossi et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Generation of Spinal Motor Neurons From Human Fetal Brain-Derived Neural Stem Cells: Role of Basic Fibroblast Growth Factor
Paivi M. Jordan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Proteomics in human Parkinson's disease research
Virginie Licker et al.
JOURNAL OF PROTEOMICS (2009)
The scientific and clinical basis for the treatment of Parkinson disease (2009)
C. Warren Olanow et al.
NEUROLOGY (2009)
Generally detected proteins in comparative proteomics - A matter of cellular stress response?
Ping Wang et al.
PROTEOMICS (2009)
MALDI Imaging of formalin-fixed paraffin-embedded tissues: Application to model animals of Parkinson disease for biomarker hunting
J. Stauber et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Proteome analysis of human substantia nigra in Parkinson's disease
Cornelius J. Werner et al.
PROTEOME SCIENCE (2008)
Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins
Jiri Petrak et al.
PROTEOMICS (2008)
Increased striatal mRNA and protein levells of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins
Anna Nilsson et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia
Barbara Valastro et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications
Robert K. McNamara et al.
SCHIZOPHRENIA RESEARCH (2007)
Analysis of the ribosomal protein S19 interactome
Stefania Orru et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Proteomic identification of a stress protein, mortalin/mthsp70/GRP75 - Relevance to Parkinson disease
Jinghua Jin et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Schizophrenia-relevant behavioral testing in rodent models: A uniquely human disorder?
Craig M. Powell et al.
BIOLOGICAL PSYCHIATRY (2006)
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse
K Sköld et al.
JOURNAL OF PROTEOME RESEARCH (2006)
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
WJ Lukiw et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
APP23 mice as a model of Alzheimer's disease: An example of a transgenic approach to modeling a CNS disorder
D Van Dam et al.
CNS SPECTRUMS (2005)
Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats
J Pierson et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Molecular profiling of experimental Parkinson's disease:: Direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry
J Pierson et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Proteome analysis of human substantia nigra in Parkinson's disease
M Basso et al.
PROTEOMICS (2004)
Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease
Y Oiwa et al.
JOURNAL OF NEUROSURGERY (2003)
Molecular imaging of amyloid β peptides in mouse brain sections using mass spectrometry
M Stoeckli et al.
ANALYTICAL BIOCHEMISTRY (2002)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Fibroblast growth factor-2 interacts with free ribosomal protein S19
F Soulet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
MA Chishti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42
CS Atwood et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Expression of PEP-19 inhibits apoptosis in PC12 cells
JA Erhardt et al.
NEUROREPORT (2000)
Share Paper
